ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
38.62
0.39%
US Tech 100
17,808.80
0.23%
S&P 500
5,282.70
0.13%
US Dollar vs CAD
1.38417
0.00%
Bitcoin
84,970.48
0.06%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Dyne Therapeutics Inc (DYN) Share Price

Dyne Therapeutics Inc

Dyne Therapeutics Inc (DYN)

NASDAQ
8.17
0.34
(4.34%)
Closed April 17 3:00PM
Delayed by 15 minutes
8.17
0.00
(0.00%)
After Hours: 5:59PM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
8.17
Bid
7.92
Ask
8.44
Volume
1,315,688
7.59 Day's Range 8.22
6.36 52 Week Range 47.45
Market Cap
924.201M
Previous Close
7.83
Open
7.82
Last Trade
1
@
8.44
Last Trade Time
Financial Volume
US$ 10,462,899
VWAP
7.9524
Average Volume (3m)
2,201,226
Shares Outstanding
113,121,357
Dividend Yield
-
PE Ratio
-2.91
Earnings Per Share (EPS)
-2.81
Revenue
-
Net Profit
-317.42M

About Dyne Therapeutics Inc

Dyne Therapeutics Inc is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. Dyne Therapeutics Inc is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.dyne-tx.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Dyne Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker DYN. The last closing price for Dyne Therapeutics was US$7.83. Over the last year, Dyne Therapeutics shares have traded in a share price range of US$ 6.36 to US$ 47.45.

Dyne Therapeutics currently has 113,121,357 shares outstanding. The market capitalization of Dyne Therapeutics is US$885.74 million. Dyne Therapeutics has a price to earnings ratio (PE ratio) of -2.91.

Ask ADVFN Intelligence (AI)

DYN Latest News

More News

Form ARS - Annual Report to Security Holders
Edgar (US Regulatory)
April 15 2025
DYN (4.34%)

Form DEF 14A - Other definitive proxy statements
Edgar (US Regulatory)
April 15 2025
DYN (4.34%)

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
March 27 2025
DYN (4.34%)

Form 8-K - Current report
Edgar (US Regulatory)
March 20 2025
DYN (4.34%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.7810.55480378897.398.176.7117674087.39671532CS
4-4.08-33.30612244912.2512.466.3626167519.24113776CS
12-5.55-40.451895043713.7217.1756.36220122611.74236478CS
26-27.24-76.927421632335.4135.76646.36171381416.50978456CS
52-16.92-67.437225986425.0947.456.36146627024.26976009CS
156-1.33-149.547.454.390652420.44941772CS
260-15.28-65.159914712223.4547.454.368610419.97301116CS

DYN - Frequently Asked Questions (FAQ)

What is the current Dyne Therapeutics share price?
The current share price of Dyne Therapeutics is US$ 8.17
How many Dyne Therapeutics shares are in issue?
Dyne Therapeutics has 113,121,357 shares in issue
What is the market cap of Dyne Therapeutics?
The market capitalisation of Dyne Therapeutics is USD 885.74M
What is the 1 year trading range for Dyne Therapeutics share price?
Dyne Therapeutics has traded in the range of US$ 6.36 to US$ 47.45 during the past year
What is the PE ratio of Dyne Therapeutics?
The price to earnings ratio of Dyne Therapeutics is -2.91
What is the reporting currency for Dyne Therapeutics?
Dyne Therapeutics reports financial results in USD
What is the latest annual profit for Dyne Therapeutics?
The latest annual profit of Dyne Therapeutics is USD -317.42M
What is the registered address of Dyne Therapeutics?
The registered address for Dyne Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Dyne Therapeutics website address?
The website address for Dyne Therapeutics is www.dyne-tx.com
Which industry sector does Dyne Therapeutics operate in?
Dyne Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MSGMMotorsport Games Inc
US$ 2.69
(140.18%)
37M
SXTCChina SXT Pharmaceuticals Inc
US$ 2.11
(113.37%)
51.73M
ADGMAdagio Medical Holdings Inc
US$ 1.68
(81.98%)
115.48M
PNBKPatriot National Bancorp Inc
US$ 3.28
(73.54%)
1.57M
RTCBaijiayun Group Ltd
US$ 0.3601
(67.49%)
187.02M
LXEHLixiang Education Holding Company Ltd
US$ 8.25
(-64.11%)
1.55M
CLIKClick Holdings Ltd
US$ 0.355
(-48.18%)
13.52M
IOTRiOThree Ltd
US$ 1.1409
(-38.33%)
3.93M
FMTOFemto Technologies Inc
US$ 0.0191
(-35.47%)
198.4M
SISIShineco Inc
US$ 0.5809
(-35.07%)
824.91k
DMNDamon Inc
US$ 0.0034
(9.68%)
409.39M
STSSSharps Technology Inc
US$ 0.03195
(20.57%)
391.8M
SUNESUNation Energy Inc
US$ 0.0176
(-10.20%)
349.4M
NVDANVIDIA Corporation
US$ 101.49
(-2.87%)
292.48M
HTZHertz Global Holdings Inc
US$ 8.205
(43.70%)
266.91M

Discussion

View Full Feed
Number sleven Number sleven 5 minutes ago
I've had one response about off topic sports convention. If that is the only response I get, those conversations will also be deleted.
Sleven,
AMRN
rooster rooster 5 minutes ago
https://x.com/1nicdar/status/1912956072396017957?s=46&t=qLQnO1TjeygtFbhEqQdlmg
rooster rooster 5 minutes ago
Good one… https://x.com/bennyjohnson/status/1912894974120648882?s=46&t=qLQnO1TjeygtFbhEqQdlmg
Orange Cassidy Orange Cassidy 6 minutes ago
Three years later are you still one or two press releases away from BLAST OFF???
In My opinion I feel we are one to two Press Releases away from total blast off!!!
NBRI
RickNagra RickNagra 8 minutes ago
https://x.com/RickNagra/status/1913037838523711860
FNMA
don estaban don estaban 8 minutes ago
I used to love snow cones hopefully it's a snow cone machine and us shareholders are invited
MVNT
Orange Cassidy Orange Cassidy 9 minutes ago
Four years later is it still worth the wait?

For me the potential here is off the chart and definitely worth the wait.
NBRI
dog786 dog786 9 minutes ago
Well it was kinda tongue and cheek. This will all work it self out. Buying opportunity
IONQ
CaptainObvious CaptainObvious 10 minutes ago
I'm thinking he'll come back when there is approval news. At least I hope so.
NWBO
TenKay TenKay 11 minutes ago
HBLM?
HMBL
Fred Kadiddlehopper Fred Kadiddlehopper 13 minutes ago
Do you think demand for Enhanz has totally evaporated?
HALO
janice shell janice shell 14 minutes ago
Oh yes. Definitely Musk. I think Vance could be handled, but he'd need to be forced to fire Vought.
ap17 ap17 15 minutes ago
TRUE!!
CORRECT! Only a complete IDIOT would think owning the ETF is the same as owning the coin! case closed🏦 and you are correct the chart idiots missed it for 3+ years now. Laughing stock of IHUB.
XRPUSD
abc1212 abc1212 16 minutes ago
https://investorshub.advfn.com/uimage/uploads/2025/4/17/fy%5ByyFlipper_message.jpg
NWBO
johnhancoque johnhancoque 16 minutes ago
Better to remain silent and be thought a fool than to open one's mouth and remove all doubt! Alon Ben Noon could have said nothing at all and let the market speculate for the past 6 months, however he thought it prudent to advise the markets and tweet rocket emojis and do cryptic interviews telling
NRSN
Fdc4 Fdc4 16 minutes ago
Well, ORCA. You are right this time. Congratulation
VDRM
Susie924 Susie924 16 minutes ago
https://x.com/timodc/status/1913035471438975483?s=46&t=HRw0TsA3C6qnjy6x_p3SQA
janice shell janice shell 17 minutes ago
Yes. Tim Miller said Lisa Murkowski ought to join Angus King as an Independent who caucuses with the Dems. And why not? People in Alaska love her.
BFarb BFarb 17 minutes ago
Lay out the next web of confusing empty promises maybe hah. I did see Rocker funder posted about Smog Armor on X today though 
DRNK
Monroe1 Monroe1 17 minutes ago
aye Mate twas a great day for trading thanks to all pigeons.... green is so good. Up strong for the year!
Looking forward to Christmas in June.
CYDY
Fred Kadiddlehopper Fred Kadiddlehopper 17 minutes ago
Jessica is among the most realistic show-me analysts and is immune to Helen's empty promises. If memory serves, she was the one who pinned Helen on the definition of "mid-single digits" royalties (which is a truly deplorable and shameless case of mendacious BS and should give pause to all who think
HALO
Susie924 Susie924 17 minutes ago
I don’t think she’s afraid of Trump. She’s afraid of all the Maga idiots out there that would harm her or her family.
Musical Shares Musical Shares 18 minutes ago
Without his BD name or FCA registration number I can't trace him or his transactions.

Island of Jersey I think only has about 103,000 people and it does seem odd that a guy from Pennsylvania is somehow linked to a financial BD there. Although Jersey is known to be a financial center.
FITY
catani catani 19 minutes ago
But make sure, John Cale is on deserved vacancies

Your Recent History

NASDAQ
DYN
Dyne Therapeutics
NASDAQ
CRML
Critical Metals
LSE
OEX
Oilex Ld
BIT
S27873
Societe Generale Effekten
LSE
63NZ
Municplty 34
LSE
79VU
Investec Bnk 26
BIT
P18VV7
BNP Paribas Issuance
NASDAQ
KTOS
Kratos Defense and Secur...
LSE
FK59
Sant Uk 28
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads